Globally trading companies depend on the analysis of export import data and customs data. This analysis offers insightful ...
The 12th round of negotiations towards a global accord on handling future pandemics ended Friday without a  final agreement, with rich and poor nations still wrangling over how to make it work.
The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.